.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Type 1 Diabetes

The AJMC® Type 1 Diabetes compendium is a comprehensive resource for news and interviews about this chronic autoimmune condition.

Understanding Autoimmunity in Type 1 Diabetes and Potential for Therapeutic Opportunities

This piece explores the history; physical, economic, and psychosocial burden; and clinical pathophysiology of type 1 diabetes to evaluate opportunities for earlier intervention to change the standard of care for this disease and improve overall outcomes.

Potential Link Found Between 3 Biomarkers, DKD Risk in Pediatric T1D

August 20th 2022, 5:05pm

Article

A study found cystatin C, renal resistance index, and urinary kidney injury molecule-1 were significantly associated with risk of diabetic kidney disease (DKD) in children and adolescents with type 1 diabetes (T1D).

Beta Cell Reactivation May Be Viable Treatment for Patients With Type 1 Diabetes

August 17th 2022, 8:28pm

Article

Researchers achieved successful reactivation of pancreatic stem cells to become insulin expressing, suggesting future potential for replacing destroyed beta cells in patients with type 1 diabetes with newborn insulin-generating cells.

Dr Viral Shah Addresses Gap in T1D Technology Uptake

August 12th 2022, 7:38pm

Video

More efforts need to be made to remove unconscious bias when implementing approved diabetes technologies into clinical practice for all patients, said Viral Shah, MD, an endocrinologist and scientist.

England's NHS Rolls Out Prescription CGMs for Patients With T1D

August 10th 2022, 8:30pm

Article

The National Health Service (NHS) in England has made the Dexcom ONE real-time Continuous Glucose Monitoring System available by prescription to patients with type 1 diabetes (T1D).

Closed-Loop Insulin Delivery Has Glycemic Benefits During Sleep, but Sleep Quality Deteriorates

August 4th 2022, 6:42pm

Article

Compared with sensor-augmented pump therapy, closed-loop insulin delivery increased glucose time in range and reduced hypoglycemia episodes but detracted from sleep quality.

Dr Viral Shah Emphasizes Payer's Role in Patient Access to T1D Treatments

August 2nd 2022, 6:12pm

Video

While therapies for type 1 diabetes (T1D) are becoming more advanced, the problem is patients can't access them, said Viral Shah, MD, an endocrinologist and scientist.

Diabetes, Osteoporosis Research Is a "Hot Topic," Says Dr Viral Shah

July 29th 2022, 5:05pm

Video

Viral Shah, MD, an endocrinologist and scientist, discusses ongoing research on preventing bone fractures in people with type 1 diabetes (T1D).

Use of Continuous Glucose Monitoring Devices Varies by Age for Patients With T1D

July 27th 2022, 3:00pm

Article

Probability of continuous glucose monitoring device use was highest for patients with type 1 diabetes (T1D) in middle adulthood, decreasing as older age increased.

Dr Viral Shah Explains His Research on Bone Fracture Predictors in T1D

July 23rd 2022, 7:14pm

Video

Viral Shah, MD, an endocrinologist and scientist, discusses his research on fracture risk assessment without bone mineral density as a predictor of major fractures in patients with type 1 diabetes (T1D).

Screenings for Autoimmune Diseases Necessary for Children, Adolescents With T1D

July 21st 2022, 2:30pm

Article

Current guidelines recommend screening for the 2 most commonly diagnosed autoimmune diseases among adolescent patients with type 1 diabetes, but researchers suggest that additional screenings could benefit patients.